Lumbar disc herniation
Conditions
Interventions
Transcutaneous peripheral nerve stimulation group - continuous wave group:Give continuous wave electrostimulation to the patient at the Neiguan and Hegu acupoints.
Transcutaneous peripheral nerve stimulation group - discontinuous wave group:Give the patient discontinuous wave electrical stimulation at the Neiguan and Hegu acupoints.
Transcutaneous peripheral nerve stimulation group - control group:Attach electrodes to the Neiguan and Hegu acupoints of the patient without turning on the power supply.
Transauricular vagus nerve stimulation group - continuous wave group:Give the patient continuous wave electrical stimulation on both tragus.
Transauricular vagus nerve stimulation group - intermittent wave group:Give the patient intermittent wave electrical stimulation on the bilateral tragus.
Transauricular Vagus Nerve Stimulation Group - Dense - Sparse Wave Group:Administer bilateral tragus dense-sparse wave electrical stimulation to the patient.
Transcutaneous peripheral nerve stimulation group - dense-disperse wave group:Apply dense-sparse wave electrostimulation to the patients Neiguan and Hegu acupoints.
Trans - Auricular Vagus Nerve Stimulation Group - Control Group:Apply electrodes to both sides of the patients ear tragus without connecting to the power supply.
Sponsors
Hebei General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.The research subjects are surgical patients who undergo transforaminal endoscopic discectomy under monitored anesthesia care at Hebei Provincial People's Hospital, with no gender restrictions, aged 18 to 65 years old, having clear consciousness and civil capacity, and without contraindications for surgery and anesthesia.
Exclusion criteria
Exclusion criteria: 1. Patients with severe respiratory depression. 2. Patients with known or suspected gastrointestinal obstruction, including paralytic ileus. 3. Patients with severe arrhythmia. 4. Patients with severe liver dysfunction. 5. Patients who refuse. 6. Patients who experience severe adverse reactions during surgery and whose operation is terminated or anesthesia method is changed. 7. Patients with epilepsy or a history of epilepsy and other neurological diseases. 8. Patients known to be allergic to oliceridine. 9. Patients with infected or damaged skin at the stimulation site.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bispectral Index, BIS;Ramsay Sedation Score;Heart rate variability (HRV);Visual Analogue Scale (VAS);MOAA/S; | — |
Secondary
| Measure | Time frame |
|---|---|
| Perfusion Index;Pulse Oximetry Saturation;Adverse reaction;blood pressure;heart rate; | — |
Countries
China
Contacts
Public ContactZhang Dong
Hebei General Hospital
Outcome results
None listed